NewsMeter

Invivyd receives Nasdaq minimum bid price deficiency notice, has until January 19, 2027 to comply

7/25/2026

$1.00 per share is the Nasdaq minimum bid price Invivyd, Inc. (IVVD) failed to clear for 30 consecutive business days, drawing a deficiency letter from the Nasdaq Listing Qualifications Department dated July 23, 2026.

Under Nasdaq Listing Rule 5810(c)(3)(A), the New Haven, Connecticut biotech has until January 19, 2027 to restore its closing bid above that floor or face removal from The Nasdaq Global Market.

The letter itself carries no immediate effect; IVVD continues to trade on Nasdaq under its existing ticker. The compliance clock The Initial Compliance Period runs from the letter date to January 19, 2027.

To cure the deficiency within that window, Invivyd must record a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days.